Now showing items 1-1 of 1
In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening
(Springer Nature, 2018-02-13)
Variability in patient response to anti-cancer drugs is currently addressed by relating genetic mutations to chemotherapy through precision medicine. However, practical benefits of precision medicine to therapy design are ...